Supreme Court ruling expected to end Roundup cancer litigation wave

The U.S. Supreme Court ruled 7-2 in favor of Bayer, the maker of Roundup, blocking state court lawsuits over failure-to-warn claims about cancer risks. The decision, which aligns with federal regulatory findings, is expected to end thousands of litigation cases but faces criticism from plaintiffs' lawyers. Bayer plans to proceed with a $7.25 billion settlement to resolve remaining claims, while Missouri resident John Durnell, who developed non-Hodgkin’s lymphoma after using Roundup, was the lead plaintiff in the case.